Take a look back at our top stories of 2024: Medical devices used for endoscopic vessel harvesting have been associated with significant safety concerns due to silicone pieces breaking off during use. In some cases, surgeons were unable to retrieve the broken pieces.
About us
Cardiovascular Business is a news, business and technology source for cardiovascular medicine. We focus on the business and economics behind the foremost clinical, interventional, surgical and information technologies as well as pharmaceuticals and related products that are key to achieving a successful integrated cardiovascular practice.
- Website
-
http://www.cardiovascularbusiness.com/
External link for Cardiovascular Business
- Industry
- Periodical Publishing
- Company size
- 11-50 employees
- Headquarters
- Providence, RI
- Type
- Privately Held
- Founded
- 2007
Locations
-
Primary
Get directions
Promenade Street
Providence, RI, US
Employees at Cardiovascular Business
Updates
-
ICYMI: FDA and Boston Scientific send urgent recall alert for more than 200,000 pacemakers after 2 deaths. #cardiology #EPeeps #EPlab #pacemaker
FDA and Boston Scientific issue urgent alert about pacemaker failures following 2 deaths
cardiovascularbusiness.com
-
The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply. #pharmacy
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders
cardiovascularbusiness.com
-
CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. A group of specialists from all over the world shared their perspective on this ongoing cardiac #imaging trend.
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD
cardiovascularbusiness.com
-
For artificial intelligence to truly transform care, the healthcare industry has a lot of work to do. Jens Eldrup-Jorgensen, MD, a veteran vascular surgeon and member of the Society for Vascular Surgery explains in a guest editorial.
Advancing AI for vascular surgery will require a commitment to data integrity
cardiovascularbusiness.com
-
An additional 15 patients will now receive the titanium total artificial heart technology from BiVACOR as they wait for a permanent transplant.
‘Incredibly rewarding’: FDA expands total artificial heart study after early success
cardiovascularbusiness.com
-
🚨 Webinar Today 🚨 Understanding plaque burden in CAD patients is critical for better outcomes. But how can you do it more accurately? Join us today for an insightful discussion featuring two cardiologists as they explore: ✅ The benefits of coronary CTA + AI-driven plaque analysis ✅ How to assess cardiovascular event risks effectively ✅ Key takeaways from the 7-year ADVANCE-DK study Don’t miss this opportunity. Register now! https://ow.ly/ZJmJ50UtpNg
Critical reasons for incorporating Plaque Analysis into your CAD Diagnosis
cardiovascularbusiness.com
-
Boston Scientific is recalling the catheters associated with its POLARx Cryoablation System due to a heightened risk of esophageal injury. The company has updated the instructions for these catheters to help minimize the risk of any additional issues going forward. #EPeeps #EPlab
FDA announces recall of cryoablation catheters after multiple injuries, including 4 deaths
cardiovascularbusiness.com
-
The new HeartBeam Inc. (NASDAQ: BEAT) technology was designed to help patients evaluate their own heart health in real time.
FDA clears credit card-sized heart monitor
cardiovascularbusiness.com